&Partners’s CONMED CNMD Stock Holding History

&Partners’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,960	Closed	-$207K	–	2134
2025 Q2	$207K	Sell	3,960 -1,438	-27%	-$78.9K	﹤0.01%	1821
2025 Q1	$318K	Buy	5,398 +750	+16%	+$48.3K	﹤0.01%	1378
2024 Q4	$313K	Buy	+4,648	New	+$324K	﹤0.01%	1312

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

&Partners's CNMD Position: Q3 2025 in Review

&Partners sold out of CONMED (CNMD) in Q3 2025, closing a stake of 3,960 shares — an estimated $207K sold.

&Partners first reported a position in CNMD in Q4 2024 and held it in 3 quarters. The position peaked at $318K in Q1 2025. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

&Partners reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
&Partners sold 3,960 CONMED shares in Q3 2025, an estimated $207K.
&Partners first reported a position in CONMED in Q4 2024 and held it in 3 quarters.
&Partners's CONMED position peaked at $318K in Q1 2025.
273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on &Partners's 13F filing for Q3 2025, filed 14 Nov 2025.